We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 27, 2021

Impact of Therapeutic Heparin vs Prophylactic Heparin on Death, Mechanical Ventilation, and ICU Admission Among Hospitalized COVID-19 Patients

BMJ : British Medical Journal


Additional Info

Disclosure statements are available on the authors' profiles:

BMJ : British Medical Journal
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial
BMJ 2021 Oct 14;375(xx)n2400, M Sholzberg, GH Tang, H Rahhal, M AlHamzah, LB Kreuziger, FN Áinle, F Alomran, K Alayed, M Alsheef, F AlSumait, CE Pompilio, C Sperlich, S Tangri, T Tang, P Jaksa, D Suryanarayan, M Almarshoodi, LA Castellucci, PD James, D Lillicrap, M Carrier, A Beckett, C Colovos, J Jayakar, MP Arsenault, C Wu, K Doyon, ER Andreou, V Dounaevskaia, EK Tseng, G Lim, M Fralick, S Middeldorp, AYY Lee, F Zuo, BR da Costa, KE Thorpe, EM Negri, M Cushman, P Jüni

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading